Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-05-06 00:00:00 ET · period of report 2022-04-29 · accession 0001567619-22-009717 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-06 | 2022-04-29 | BMRN | Mueller Brian | EVP, CFO | A - Grant | $62.41 | +340 | 38.6K | +0.9% | +$21.2K |
| DM | 2022-05-06 | 2022-05-04 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $37.46 | +11.8K | 48.4K | +32% | +$442.0K |
| DM | 2022-05-06 | 2022-05-04 | BMRN | Mueller Brian | EVP, CFO | S - Sale+OE | $84.50 | -11.8K | 38.6K | -23% | -$997.1K |
| DM | 2022-05-06 | 2022-05-04 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $0.00 | -11.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-29 | A | A | 340 | $62.41 | 38,639 | D | — | — | (F1) Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-05-04 | M | A | 2,038 | $37.46 | 40,677 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 3 | Common | Common Stock | 2022-05-04 | S | D | 9,762 | $84.50 | 38,639 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 4 | Common | Common Stock | 2022-05-04 | M | A | 9,762 | $37.46 | 48,401 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 5 | Common | Common Stock | 2022-05-04 | S | D | 2,038 | $84.50 | 38,639 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 6 | Derivative | Stock Option (Right to buy Common Stock) | 2022-05-04 | M | D | 9,762 | $0.00 | 0 | D | $37.46 · 2012-11-08 to 2022-05-07 | 9,762 Common Stock | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |
| 7 | Derivative | Stock Option (Right to buy Common Stock) | 2022-05-04 | M | D | 2,038 | $0.00 | 0 | D | $37.46 · 2012-11-08 to 2022-05-07 | 2,038 Common Stock | (F2) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. (F3) Reflects the number of options outstanding after the transactions from this specific stock option grant. |